Understanding the Chronic Disease Patient Journey in Emerging Markets
The benefits of understanding the patient journey are well documented in mature markets. But in emerging markets the patient journey is less understood. We recently presented a webinar hosted by Pharmaceutical Executive where we addressed the changing emerging market healthcare environment and explored the challenges and differences in the patient journey. In this article I wanted to share some of these learnings.
Latest wave of Therapy Watch IBD to run this month
The IBD syndicated market tracker is part of our large auto-immune portfolio.
This month, Therapy Watch IBD will be running in the 5 EU markets of France, Germany, Italy, Spain and the UK. A panel of 200 gastroenterologists will report in 10 IBD patient record forms each quarter (5 Crohn’s disease and 5 ulcerative colitis), to monitor the evolving IBD treatment landscape.
Research Partnership launches new patient report - Living with Lupus (SLE)
Living with Lupus (SLE) is a quantitative study conducted online amongst patients in the US and European markets. The report will consist of 30-minute face to face interviews with a broad sample of SLE patients, 40% of patient across all markets will currently be receiving a biologic and an additional sub sample will be patients suffering from Lupus Nephritis. The findings will be analysed and will be available to purchase early December 2016.
Webinar: Ensuring an Actionable Segmentation
A segmentation study comes with high visibility and high stakes across your marketing and sales organisations. Ensuring that a segmentation is actionable is a consistent issue, particularly when stakeholders with multiple interests are involved. Download our latest webcast in which our quantitative experts Tom Nolte and Dr Marianne Jaeger will utilise knowledge and experience garnered from more than 25 years of conducting global segmentations, to explore some of the key segmentation challenges and show you how to ensure adoption and use across your business.
Interactive infographic: LATAM
An overview of the six most-commonly researched, largest pharma markets in Latin America
The LATAM region's largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region. With pharmaceutical sales of more than $64bn, it is an attractive market for pharma, however it is also one in which each market differs in terms of opportunities and challenges.